+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anticancer efficacy of allogeneic vaccine modified with progenitor neural cells supernatant in rats with glioma 101.8

Anticancer efficacy of allogeneic vaccine modified with progenitor neural cells supernatant in rats with glioma 101.8

Experimental Oncology 37(3): 203-207

The aim of the work was to investigate the antitumor efficacy of allogeneic tumor vaccine (ATV) modified with rat progenitor neural cell supernatant (RPNS) in rats with glioma 101.8. The study was performed on 74 white random-bred rats. ATV was developed on the basis of glioma 101.8 cell suspension modified with RPNS (0.02 or 0.10 mg/ml). RPNS was prepared from suspension made from whole rat brain tissue on 14(th) (E14) day of gestation. Model of brain glioma 101.8 was reproduced by intracerebral injection of glioma 101.8 cell suspension. ATV was injected intraperitoneally in a volume of 0.2 ml per animal once on the 10(th) day after tumor transplantation. For survival analysis Kaplan - Mayer multiple assessments method was used. Cytotoxic activity of rat lymphocytes (effector cells) was evaluated in MTT-colorimetric test by determining the state of mitochondrial dehydrogenase enzymes in target cells (allogeneic glioma 101.8 cells). Intraperitoneal administration of ATV modified with 0.10 mg/ml RPNS significantly increased mean survival time and median survival of glioma-bearing rats compared with unvaccinated group (MST (19.9 ± 2.4), 21.4 days; versus MST (14.6 ± 2.8); 14 days; p = 0.0002, Gehan's - Wilcoxon test). Intraperitoneal administration of ATV modified with 0.10 mg/ml RPNS resulted in increased cytotoxic activity of immune cells of rats with glioma in vitro compared with this index in unvaccinated group (p = 0.026, U-Mann - Whitney test). Antitumor effect of vaccination with RPNS-modified ATV is realized via increased cytotoxic activity of immune cells, what could be used for further optimization of whole tumor cell vaccine.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 057210965

Download citation: RISBibTeXText

PMID: 26422105

Related references

The Influence Of Progenitor Neuro- Cells Supernatant On The Lympho- Cytes Cytotoxic Function In Rats With Glioma. Fiziolohichnyi Zhurnal 61(4): 63-70, 2015

Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. European Journal of Neuroscience 26(6): 1462-1478, 2007

Neural progenitor and hemopoietic stem cells inhibit the growth of low-differentiated glioma. Bulletin of Experimental Biology and Medicine 152(4): 497-503, 2012

Cross-talk between human neural stem/progenitor cells and peripheral blood mononuclear cells in an allogeneic co-culture model. Plos one 10(2): E0117432, 2015

Study on the therapeutic effect of neural progenitor cells in mice of a glioma murine model. Oncology Letters 11(3): 2067-2070, 2016

High titer retroviral gene transduction to neural progenitor cells for establishment of donor cells for neural transplantation to parkinsonian model rats. NeurologiaMedico-Chirurgica44(7):344, 2004

Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant. Cancer Research 57(15): 3230-3237, 1997

Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model. Journal of Cellular and Molecular Medicine 17(11): 1434-1443, 2013

Novel anticancer vaccine using genetically modified endothelial cells. European Urology Suppl.s 2(1): 44, 2003

Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma. Experimental Cell Research 312(8): 1265-1276, 2006

Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma. Stem Cells Translational Medicine 1(12): 866-873, 2012

Mobilization of peripheral blood progenitor cells for allogeneic peripheral blood progenitor cell transplantation Efficacy and toxicity of a high dose rhG-CSF regimen. Bone Marrow Transplantation 17(Suppl. 2): S71, 1996

A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells. Neuro-Oncology 12(7): 645-654, 2010

Differential sensitivity of human glioma cell cultures to the lak cells inhibitory effect of the glioma supernatant on lak activity generation. Journal of Interferon Research 11(Suppl. 1): S218, 1991

Chemokine CXC receptor 4--mediated glioma tumor tracking by bone marrow--derived neural progenitor/stem cells. Molecular Cancer Therapeutics 8(9): 2746-2753, 2009